Equity Research
William Blair research analyst Myles Minter was quoted by MedCity News in its coverage of Moderna’s approvals for a vaccine that provides combined coverage against COVID-19 and the flu and its impact for investors.
“The key question for us is how much of the flu vaccination market Moderna can now capture with a combination vaccine,” Minter’s note to investors that was cited by the publication said.
Stay up-to-date with the latest William Blair news and insights
William Blair, in conjunction with its Asian affiliate, BDA Partners, acted as exclusive financial advisors to Farsound Aviation Limited, a portfolio company of AGIC Capital, in connection with its pending sale to Onex Partners Opportunities Fund.
Read moreExperiencing the death of someone close to you—whether a spouse, longtime partner, or family member—can be difficult.
Read moreIRA owners who are age 70½ or older and charitably inclined may consider making Qualified Charitable Distributions from their IRAs as a tax efficient way to fund charitable goals.
Read moreInformation contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
